The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells. J. Can. Res. Updates [Internet]. 2014 Apr. 28 [cited 2025 Oct. 21];3(2): 108-116. Available from: https://neoplasiaresearch.com/index.php/jcru/article/view/558